EGFR and prostate adenocarcinoma: EGFR gene amplification, associated or not to EGFRvIII mutant expression, is frequently observed in other tumors like gliomas [5], [52], [63], [64], [65], [66], lung cancers [67], [68], breast [69], and prostate adenocarcinomas [70].